Clinical value of SonoVue contrast-enhanced ultrasonography in the evaluation of chronic renal insufficiency

XING Jin-fang
DOI: https://doi.org/10.3969/j.issn.1003-6350.2013.24.1511
2013-01-01
Abstract:Objective To research the clinical value of SonoVue contrast-enhanced ultrasonography in the evaluation of patients with chronic renal insufficiency. Methods Sixty patients with renal allograft, including 38 males and 22 females, were enrolled into this study, which were divided into the control group(n=30, with normal renal function) and the study group(n=30, with chronic renal insufficiency). Time after transplantation in all the patients was more than six months. Sequoia512(SIEMENS, Mountain View) equipped with contrast software of contrast pulsed sequences were used, with ultrasound contrast agent of SonoVue(Bracco,Italy). Patients were placed as supine position, and subsequently evaluated by SonoVue ultrasound contrast imaging after conventional ultrasound imaging. The images were stored real-timely and analyzed by review. The main outcome measuring indicators included the time of agent starting perfusing(ST), time of agent perfuming arriving peak value(PT), time of agent perfuming(T) and were echo peak intensity(PI). Results All the 60 patients were successfully examined with ultrasound contrast imaging. All images of ultrasound contrast were in line with the analysis standard. The indicators(PT, T, PI) were significantly different between the two groups(P<0.05). Conclusion Renal graft cortex microcirculation perfusion changes of chronic renal insufficiency can be monitored by SonoVue contrast ultrasound imaging, and its clinical value is superior to two-dimensional ultrasonograph.
What problem does this paper attempt to address?